APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 130 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $185,158,000 | -5.3% | 2,929,708 | -35.7% | 1.91% | -1.4% |
| Q1 2021 | $195,585,000 | -32.0% | 4,558,029 | -9.4% | 1.93% | -15.5% |
| Q4 2020 | $287,618,000 | +89.6% | 5,028,289 | 0.0% | 2.29% | +99.0% |
| Q3 2020 | $151,703,000 | -7.6% | 5,028,289 | 0.0% | 1.15% | -23.5% |
| Q2 2020 | $164,224,000 | +21.9% | 5,028,289 | 0.0% | 1.50% | -17.3% |
| Q1 2020 | $134,708,000 | -6.0% | 5,028,289 | +7.5% | 1.82% | +1.7% |
| Q4 2019 | $143,249,000 | +27.1% | 4,678,289 | 0.0% | 1.78% | +15.2% |
| Q3 2019 | $112,700,000 | +72.4% | 4,678,289 | +81.3% | 1.55% | +6.0% |
| Q2 2019 | $65,370,000 | +29.9% | 2,579,708 | 0.0% | 1.46% | +4.4% |
| Q1 2019 | $50,304,000 | +71.0% | 2,579,708 | +15.7% | 1.40% | +14.8% |
| Q4 2018 | $29,410,000 | – | 2,229,708 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |